Test

The treatment of multiple pathological processes that affect the bone and the joints (fractures, joint degeneration, etc.) requires the placement of bone implants. A significant percentage of these implants fail and must be replaced, entailing a human and economic cost. Various factors have been related to implant failure, including poor osteointegration, aseptic loosening, peri-implant inflammation, and local bone deficiencies. In view of this problem, our new patent offers a new generation of pharmacologically treated implants that can prevent implant failure and facilitate personalized medicine with implants adapted to the needs of patients